- Home
- ITRG vs TIL Comparison
ITRG vs TIL Comparison
Compare ITRG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | TIL |
|---|---|---|
| Founded | 1997 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 586.3M | 74.7M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ITRG | TIL |
|---|---|---|
| Price | $2.83 | $8.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.13 | ★ $125.00 |
| AVG Volume (30 Days) | ★ 3.2M | 21.0K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.39 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.16 | $5.67 |
| 52 Week High | $4.87 | $42.75 |
Technical Indicators
Market Signals| Indicator | ITRG | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 51.35 |
| Support Level | $2.60 | $8.07 |
| Resistance Level | $3.24 | $9.05 |
| Average True Range (ATR) | 0.18 | 0.47 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 53.72 | 71.21 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.